Filing Details
- Accession Number:
- 0001209191-21-014776
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-26 16:36:59
- Reporting Period:
- 2021-02-25
- Accepted Time:
- 2021-02-26 16:36:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428522 | Radius Health Inc. | RDUS | Pharmaceutical Preparations (2834) | 800145732 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1830943 | Sal Grausso | C/O Radius Health, Inc. 22 Boston Wharf Road, 7Th Floor Boston MA 02210 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-02-25 | 1,322 | $18.93 | 11,709 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.